MeiraGTx Holdings (MGTX) Leases (2018 - 2025)
MeiraGTx Holdings posted quarterly Leases of $12.9 million for Q4 2025, down 42.1% year-on-year from $22.2 million in Q4 2024, and down 1.62% on a QoQ basis from $13.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 8 years of Leases data on file, last reported at $12.9 million in Q4 2025.
- For the quarter ending Q4 2025, Leases fell 42.1% year-over-year to $12.9 million; the trailing twelve-month figure through Dec 2025 stood at $12.9 million (down 42.1% YoY), and the FY2025 full-year result was $12.9 million, down 42.1% from the prior year.
- Leases for Q4 2025 stood at $12.9 million, down from $13.1 million in the prior quarter.
- Across five years, Leases topped out at $29.4 million in Q1 2021 and bottomed at $6.3 million in Q1 2025.
- The 5-year median for Leases is $23.7 million (2023), against an average of $21.0 million.
- The widest annual swing landed in 2021, when Leases jumped 345.73%; it then sank 73.2% in 2025.
- A 5-year view of Leases shows it stood at $22.8 million in 2021, then grew by 8.5% to $24.7 million in 2022, then tumbled by 35.63% to $15.9 million in 2023, then soared by 39.52% to $22.2 million in 2024, then slumped by 42.1% to $12.9 million in 2025.
- The last three Leases figures came in at $12.9 million (Q4 2025), $13.1 million (Q3 2025), and $24.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 12.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.85 Mn |
| Sep 30, 2025 | 13.06 Mn |
| Jun 30, 2025 | 24.15 Mn |
| Mar 31, 2025 | 6.35 Mn |
| Dec 31, 2024 | 22.20 Mn |
| Sep 30, 2024 | 12.78 Mn |
| Jun 30, 2024 | 13.82 Mn |
| Mar 31, 2024 | 23.69 Mn |
| Dec 31, 2023 | 15.91 Mn |
| Sep 30, 2023 | 23.68 Mn |
| Jun 30, 2023 | 24.63 Mn |
| Mar 31, 2023 | 24.85 Mn |
| Dec 31, 2022 | 24.72 Mn |
| Sep 30, 2022 | 19.91 Mn |
| Jun 30, 2022 | 24.77 Mn |
| Mar 31, 2022 | 26.77 Mn |
| Dec 31, 2021 | 22.78 Mn |
| Sep 30, 2021 | 28.43 Mn |
| Jun 30, 2021 | 24.67 Mn |
| Mar 31, 2021 | 29.45 Mn |
| Dec 31, 2020 | 21.49 Mn |
| Sep 30, 2020 | 18.08 Mn |
| Jun 30, 2020 | 6.49 Mn |
| Mar 31, 2020 | 6.61 Mn |
| Dec 31, 2019 | 7.14 Mn |
| Sep 30, 2019 | 22.11 Mn |
| Jun 30, 2019 | 6.97 Mn |
| Mar 31, 2019 | 7.26 Mn |
| Dec 31, 2018 | 95,880.00 |